ANSYS - FDA - Avicenna
Roundtable Discussion

SAVE THE DATE! Roundtable discussion in Washington on 11 October 2019

 

For those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?". 

 

The goal of the meeting is to discuss opportunities and challenges when utilizing in silico approaches during development and regulatory review.  The event will be organized around 2 panel discussions, where senior leaders from the largest medical device and pharmaceutical companies will be sharing their experience and expectations.

When and where: 11 October 2019, Marriott at Hyattsville Maryland (same hotel as BMES Conference).

 

Please register here to reserve your spot.

Do not hesitate to contact Krista Loeffler at krista.loeffler@ansys.com for more information.

 

The draft agenda is structured as follows:

Avicenna Alliance news

The Commission launched a new call for advanced health approaches to rapidly respond to COVID-19

On 19 May the European Commission launched a new call for an Expression of Interest with a budget of...

find out more ›

Members of the European Parliament call for supporting health policies and health systems in the next Multiannual Financial Framework

On 1 May Members of the European Parliament (MEPs) sent a letter...

find out more ›

Launch of the European COVID-19 Data Platform

On 20 April the Commission together with EU Member States and several partners, including EMBL’s European Bioinformatics Institute (EMBL-EBI) and...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up